Suppr超能文献

针对与良性肿瘤相关的继发性三叉神经痛的两阶段肿瘤及半月神经节三叉神经靶向伽玛刀放射外科治疗

Two-Session Tumor and Retrogasserian Trigeminal Nerve-Targeted Gamma Knife Radiosurgery for Secondary Trigeminal Neuralgia Associated with Benign Tumors.

作者信息

Park Seong-Cheol, Lee Do Hee, Lee Jung Kyo

机构信息

Department of Neurosurgery, Asan Medical Center, Seoul, Korea.

Department of Neurosurgery, Asan Medical Center, Seoul, Korea; College of Medicine, University of Ulsan, Ulsan, Korea.

出版信息

World Neurosurg. 2016 Dec;96:136-147. doi: 10.1016/j.wneu.2016.08.082. Epub 2016 Aug 28.

Abstract

OBJECTIVE

To investigate gamma knife radiosurgery (GKS) for benign tumor-associated secondary trigeminal neuralgia (TN).

METHODS

Between 2006 and 2015, 21 patients with secondary TN due to meningioma were treated using GKS. Their mean age was 56.5 ± 12.2 years. The 50% isodose was 12.5 ± 1.1 Gy for the first GKS for the meningioma. Retrogasserian targeting of the trigeminal nerve at 90 Gy with a 4-mm collimator was used for the second GKS.

RESULTS

The pain duration until GKS was 1.9 ± 1.9 years. The meningiomas were located in the cisternal space in 13 patients (56.5%) and involved the skull base in 8 patients (43.5%). The mean duration of follow-up was 3.7 ± 2.7 years. The pain control outcome was a Marseilles Pain Scale (MPS) score of I to IV in 15 patients (71%) and a score of V in 6 patients (29%). For these latter patients, we performed a second GKS targeting the trigeminal nerve and resulting in MPS scores of I to IV. The tumor size did not increase in any patient and decreased by >10% in 12 (80%) of the 15 patients who were followed for at least 1 year. Trigeminal nerve visibility may improve after tumor shrinkage. Retrogasserian trigeminal nerve targets may be used even with invisible trigeminal nerves using Meckel's cave as an anatomic marker.

CONCLUSIONS

Here we show the reproducible feasibility of a 2-session GKS procedure using higher radiation doses, the first dose to treat the tumor and the second to treat the trigeminal nerves using retrogasserian targeting.

摘要

目的

探讨伽玛刀放射外科治疗(GKS)用于良性肿瘤相关的继发性三叉神经痛(TN)。

方法

2006年至2015年期间,21例因脑膜瘤导致继发性TN的患者接受了GKS治疗。他们的平均年龄为56.5±12.2岁。首次针对脑膜瘤进行GKS时,50%等剂量线为12.5±1.1 Gy。第二次GKS采用4毫米准直器,以90 Gy对三叉神经进行半月节后靶向治疗。

结果

至GKS治疗时的疼痛持续时间为1.9±1.9年。脑膜瘤位于脑池间隙的有13例患者(56.5%),累及颅底的有8例患者(43.5%)。平均随访时间为3.7±2.7年。疼痛控制结果为,15例患者(71%)的马赛疼痛量表(MPS)评分为I至IV级,6例患者(29%)的评分为V级。对于后一组患者,我们对三叉神经进行了第二次GKS治疗,结果MPS评分为I至IV级。所有患者的肿瘤大小均未增加,在至少随访1年时间的15例患者中(80%),有12例患者的肿瘤大小缩小>10%。肿瘤缩小后三叉神经的可视性可能改善。即使三叉神经不可见,也可将半月节后三叉神经靶点作为解剖标志,以Meckel腔为定位依据。

结论

我们在此展示了一种分两阶段进行GKS治疗方案的可重复可行性,即第一阶段使用较高辐射剂量治疗肿瘤,第二阶段使用半月节后靶向治疗三叉神经。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验